5/29
08:00 am
eq
Equillium to Present at the Jefferies Global Healthcare Conference
Low
Report
Equillium to Present at the Jefferies Global Healthcare Conference
5/17
11:07 am
eq
Equillium, Inc. (NASDAQ: EQ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Neutral
Report
Equillium, Inc. (NASDAQ: EQ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
5/14
08:15 am
eq
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease [Yahoo! Finance]
Neutral
Report
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease [Yahoo! Finance]
5/14
08:00 am
eq
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
Neutral
Report
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
5/9
07:44 pm
eq
Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
High
Report
Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
5/9
04:35 pm
eq
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights [Yahoo! Finance]
High
Report
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights [Yahoo! Finance]
5/9
04:01 pm
eq
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
High
Report
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
5/7
08:25 am
eq
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists [Yahoo! Finance]
Low
Report
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists [Yahoo! Finance]
5/7
08:00 am
eq
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
Low
Report
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
5/2
06:16 am
eq
We're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn Rate [Yahoo! Finance]
4/3
08:24 am
eq
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
4/3
08:00 am
eq
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4/2
09:01 am
eq
Equillium, Inc. (NASDAQ: EQ) had its price target raised by analysts at HC Wainwright from $4.00 to $5.00. They now have a "buy" rating on the stock.
Medium
Report
Equillium, Inc. (NASDAQ: EQ) had its price target raised by analysts at HC Wainwright from $4.00 to $5.00. They now have a "buy" rating on the stock.
4/1
11:39 am
eq
5 Stocks That More Than Doubled in Q1 With More Gains Ahead [Yahoo! Finance]
Medium
Report
5 Stocks That More Than Doubled in Q1 With More Gains Ahead [Yahoo! Finance]
4/1
08:19 am
eq
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis [Yahoo! Finance]
High
Report
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis [Yahoo! Finance]
4/1
08:00 am
eq
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
Medium
Report
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
3/25
06:44 pm
eq
Equillium, Inc. (EQ) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
High
Report
Equillium, Inc. (EQ) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
3/25
04:06 pm
eq
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights [Yahoo! Finance]
High
Report
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights [Yahoo! Finance]
3/25
04:01 pm
eq
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
High
Report
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
3/22
08:00 am
eq
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
Low
Report
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
3/22
06:59 am
eq
Individual investors account for 41% of Equillium, Inc.'s (NASDAQ:EQ) ownership, while insiders account for 20% [Yahoo! Finance]
Low
Report
Individual investors account for 41% of Equillium, Inc.'s (NASDAQ:EQ) ownership, while insiders account for 20% [Yahoo! Finance]